SBFM Sunshine Biopharma Inc.

$1.06▼ -2.30% Healthcare Other
After hours $1.04▼ -1.79% Sep 11, 7:59 PM ET
Volume 99.9K Avg Volume (10D) 186.4K
Key Metrics & Fundamentals
Market Cap
$4.11M
P/E Ratio
–
Div Yield
–%
52W Range
1.01 - 24.30
% vs 50 MA
-25.93%
% vs 200 MA
-86.31%
RSI-14
33.6
MACD Histogram
+0.0200
Beta (1Y vs SPY)
1.07
Free Cash Flow
-$923,097
Gross Rev
$9.26M
Gross Profit
$2.43M
EBITDA
-$1.53M
COGS
$6.84M
Operating Exp
$4.04M
Operating Income
-$1.61M
EBIT
-$1.61M
Pretax Income
-$1.56M
Net Income
-$1.56M
EPS (Diluted)
-1.15
Price & Volume History
Loading chart…
Recent News
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions
ACCESS Newswire · Aug 31, 2026 1:00 PM
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
GlobeNewswire · Aug 26, 2026 1:20 PM
Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer
ACCESS Newswire · Aug 26, 2026 1:00 PM
EXCLUSIVE: Sunshine Biopharma Advances Vaccine Strategy for Lung Cancer
Benzinga · Aug 26, 2026 12:31 PM
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
ACCESS Newswire · Aug 19, 2026 1:00 PM
EXCLUSIVE: Sunshine Biopharma Secures Canadian Approval for Generic Hypertension Drug
Benzinga · Aug 19, 2026 12:30 PM
Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market
ACCESS Newswire · Aug 7, 2026 1:00 PM
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
ACCESS Newswire · Aug 4, 2026 1:00 PM
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval
Benzinga · Aug 4, 2026 12:31 PM
Sunshine Biopharma Receives Health Canada Approval for Generic Ondansetron to Treat Chemotherapy-Induced Nausea
MT Newswires · Jul 28, 2026 12:37 PM
Financial Overview - Income Statement Quarterly

See SBFM's money flow as a full page

Social Sentiment
Avg +0.46 · 5 posts
NewsDiscussionTradeNot Every Small Biotech Is Pre-Revenue, This One Already Sells Product
r/investing · Dec 16, 2025
The post highlights SBFM's revenue generation and product sales, presenting a positive view of the company.
positive +0.70
NewsDiscussionWhat Happens to Microcaps When Rates Fall
r/investing · Oct 28, 2025
SBFM is explicitly listed as a past example of a microcap that benefited from rate cuts.
positive +0.70
NewsDiscussionPriceTargetSBFM Announces Breakthrough Research Results on Company’s K1.1 mRNA Product as a Novel Therapeutic Agent for HCC (liver cancer)
r/wallstreetbets · Dec 3, 2024
The announcement of breakthrough research results suggests a positive outlook for the company.
positive +0.80
DDPriceTargetA1 Releases September's 5 most undervalued stocks
r/wallstreetbets · Sep 2, 2024
Part of a selection presented as a promising investment.
positive +0.60
What do you think about SBFM?
r/stocks · May 24, 2024
The post expresses uncertainty about the company's future, citing being heavily shorted and suggesting it could be a 'lost cause'.
negative -0.50
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙